SÃO PAULO, July 31, 2024 /PRNewswire/ — 2Q24 Highlights Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) of R$ 2.6 billion in the second quarter, down 6.7% compared to 1Q24. Investments (CAPEX) totaled R$ 1.4 billion in 2Q24, of which R$ 704 million was…

As a result, Wilson’s historic and groundbreaking career at the University of Pennsylvania will transition as he spearheads new entities PHILADELPHIA, July 31, 2024 /PRNewswire/ — Today, James Wilson, MD, PhD, director of the Gene Therapy Program (“GTP”), Rose H. Weiss Professor and…